MicroRNA dysregulation in gastric cancer: a new player enters the game

W K K Wu1, C W Lee, C H Cho

  • 1Department of Medicine and Therapeutics, Institute of Digestive Diseases, LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, PR China.

Oncogene
|August 31, 2010
PubMed

Insights

MicroRNAs (miRNAs) play a crucial role in gastric cancer development by regulating cell growth and spread. Understanding miRNA dysregulation offers new diagnostic and therapeutic strategies for this disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric carcinogenesis involves genetic and epigenetic changes in key genes.
  • MicroRNAs (miRNAs), a class of noncoding RNA, are increasingly recognized for their role in cancer.
  • Differential expression of miRNAs in gastric cancer tissues suggests their involvement in tumorigenesis.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in the pathogenesis of gastric cancer.
  • To explore the potential of miRNAs as diagnostic and prognostic biomarkers for gastric cancer.
  • To understand how miRNA dysregulation contributes to malignant phenotypes in gastric cancer cells.

Main Methods:

  • Analysis of differential miRNA expression in gastric cancer tissues.
  • Characterization of miRNA genes as novel proto-oncogenes and tumor-suppressor genes.
  • Investigation of miRNA polymorphisms and their association with gastric cancer risk.

Main Results:

  • A significant number of miRNAs are differentially expressed in gastric cancer.
  • miRNA dysregulation promotes cell-cycle progression, apoptosis resistance, invasiveness, and metastasis.
  • Certain miRNA gene polymorphisms are linked to increased risk of atrophic gastritis and gastric cancer.
  • Circulating miRNAs show potential as early diagnostic and prognostic markers.

Conclusions:

  • MicroRNAs are critical regulators in gastric cancer development and progression.
  • Dysregulated miRNAs can be considered novel oncogenes or tumor suppressors in gastric cancer.
  • miRNAs hold promise as biomarkers for early diagnosis and prognosis, and as therapeutic targets.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...